Home

Genomic Valley Biotech Ltd PE Ratio

Image

Genomic Valley Biotech Ltd

NSE: GENOMICVALLEY

PE

93.3

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Genomic Valley Biotech Ltd is 93.3 as of 15 Jan 10:23 AM .
  • The P/E Ratio of Genomic Valley Biotech Ltd changed from 694.2 on March 2024 to 694.2 on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Latest Trading Price of Genomic Valley Biotech Ltd is ₹ 77.44 as of 14 Jan 15:30 .
  • The PE Ratio of Miscellaneous Industry has changed from 122.9 to 64.1 in 5 years. This represents a CAGR of -12.21%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Miscellaneous industry is 64.1. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Genomic Valley Biotech Ltd

No data available

Company Fundamentals for Genomic Valley Biotech Ltd

Image

Genomic Valley Biotech Ltd

NSE: GENOMICVALLEY

Share Price

₹ 77.44

-4.07 (-4.99%)

stock direction

Last updated on: Jan 14, 2025

Market Price of Genomic Valley Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Genomic Valley Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 202577.44
13 Jan 202581.51
10 Jan 202585.79
09 Jan 202590.12
08 Jan 202588.95
07 Jan 202588.13
06 Jan 202583.94
03 Jan 202583.89
02 Jan 202582.28
01 Jan 202581.75

BlinkX Score for Genomic Valley Biotech Ltd

Asset Value vs Market Value of Genomic Valley Biotech Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Genomic Valley Biotech Ltd23.65
GMR Airports Ltd76489
International Gemmological Institute (India) Ltd23710
Sagility India Ltd22709
Godrej Agrovet Ltd13752

PE Ratio of Genomic Valley Biotech Ltd Explained

``

23.65

Market cap

0

Earnings

93.3X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Miscellaneous Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Genomic Valley Biotech Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Genomic Valley Biotech Ltd

No data available

* All values are in %

About Genomic Valley Biotech Ltd

  • Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
  • The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
  • Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
  • Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

Genomic Valley Biotech Ltd News Hub

Genomic Valley Biotech standalone net profit rises 650.00% in the September 2024 quarter

Net profit of Genomic Valley Biotech rose 650.00% to Rs 0.15 crore in the quarter ended September 20

Read more

2024-10-08 00:00:00

Genomic Valley Biotech to discuss results

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 7 October 202

Read more

2024-10-03 00:00:00

Genomic Valley Biotech schedules AGM

Genomic Valley Biotech announced that the Annual General Meeting(AGM) of the company will be held on

Read more

2024-12-07 00:00:00

Genomic Valley Biotech to convene board meeting

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 6 December 20

Read more

2024-12-03 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Genomic Valley Biotech Ltd

What is the current PE Ratio of Genomic Valley Biotech Ltd?

The Current PE Ratio of Genomic Valley Biotech Ltd is 93.3 as on 15 Jan 2025.

What is the average PE Ratio of the Miscellaneous industry?

The average industry PE Ratio of Miscellaneous is 64.1 as on 15 Jan 2025.

What was the PE Ratio of Genomic Valley Biotech Ltd last year?

The PE Ratio of Genomic Valley Biotech Ltd was 0.0 last year, now the PE ratio is 93.3, showing a year-on-year growth of -%.

What does the PE Ratio of Genomic Valley Biotech Ltd indicate about its stock?

The PE Ratio of Genomic Valley Biotech Ltd is 93.3. This ratio indicates that investors are willing to pay 93.3 times the earnings per share for each share of Genomic Valley Biotech Ltd.

What is the PE Ratio Growth of Genomic Valley Biotech Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Genomic Valley Biotech Ltd grew by -% whereas, the EPS ratio grew by 14.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions